DrugPatentWatch Archives
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: promethazine hydrochloride
Summary for Generic Name: promethazine hydrochloride
| |||||||||||||
Clinical Trials for: promethazine hydrochloridePharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine Status: Recruiting Condition: Drug Metabolism, Poor, CYP2D6-RELATED Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine Status: Completed Condition: Sleep Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers Status: Completed Condition: Focus of Study: Absorption of the Three Components in the Topical ABH Gel in Healthy Volunteers, and Determine if There Are Any Adverse Effects. Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Patients With Nausea Status: Recruiting Condition: Nausea and Vomiting A Dose Ranging Effect of Preoperative Diphenhydramine on Postoperative Quality of Recovery After Ambulatory Surgery Status: Completed Condition: Surgery; Pain To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses Status: Completed Condition: Nasal Congestion Diphenhydramine for Acute Migraine Status: Recruiting Condition: Migraine Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis Status: Completed Condition: Aphthous Stomatitis Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride Combination Status: Completed Condition: Therapeutic Equivalence Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition Status: Completed Condition: Healthy Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | REMSED | promethazine hydrochloride | TABLET; ORAL | 083176 | Approved Prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zydus Pharms Usa | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET; ORAL | 040596 | Nov 18, 2005 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Watson Labs | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET; ORAL | 085664 | Approved Prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Watson Labs | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET; ORAL | 083711 | Approved Prior to Jan 1, 1982 | RX | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc